Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06550375 · ClinicalTrials.gov registry record

Clinical Outcomes With Bilateral Implantation of Odyssey IOLs

A clinical trial of Cataract, sponsored by Mann Eye Institute.

Completed
Registry status
40
Enrollment target
1
Study location

NCT06550375 is a study of Cataract that has completed, run by Mann Eye Institute. The registered enrollment target is 40 participants, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06550375, a study of Cataract, has completed, sponsored by Mann Eye Institute.

COMPLETED
Registry status
40 participants
Enrollment target
1
Study location

Study Summary

This study is a single center, ambispective study of visual outcomes after successful bilateral cataract surgery. Subjects will be assessed at least 3 months postoperatively at a single visit. Clinical evaluations will include administration of the AIOLIS and OSDI questionnaires, as well as measurement of visual acuities at distance, intermediate, and near.

Conditions Studied

Interventions

  • DEVICE TECNIS Odyssey IOL

Study Locations (1)

Texas

  • Mann Eye Institute - Houston

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2024-09-05
Est. Completion 2025-03-26

Sponsor

Mann Eye Institute

6 total trials

What the Registry Record Tells You About NCT06550375

The ClinicalTrials.gov registry entry for NCT06550375 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (82% lower). The listed sponsor is Mann Eye Institute, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cataract appearing as the primary indexed condition, and to 1 intervention - of which TECNIS Odyssey IOL is the first listed.

NCT06550375 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06550375 about?

NCT06550375 is a clinical study titled "Clinical Outcomes With Bilateral Implantation of Odyssey IOLs". This study is a single center, ambispective study of visual outcomes after successful bilateral cataract surgery. Subjects will be assessed at least 3 months postoperatively at a single visit. Clinical evaluations will include administration of the AIOLIS and OSDI questionnaires, as well as measurem...

What is the current status of trial NCT06550375?

This trial is currently completed. The enrollment target is 40 participants. The study started on 2024-09-05. Estimated completion is 2025-03-26.

What conditions does trial NCT06550375 study?

This clinical trial studies the following conditions: Cataract.

What interventions are being tested in trial NCT06550375?

The interventions under investigation include: TECNIS Odyssey IOL (DEVICE).

Who is sponsoring clinical trial NCT06550375?

This trial is sponsored by Mann Eye Institute, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06550375 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cataract

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.